As of 2026-10-05, the EV/EBITDA ratio of Novocure Ltd (NVCR) is -13.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Novocure's latest enterprise value is 1,841.95 mil USD. Novocure's TTM EBITDA according to its financial statements is -136.58 mil USD. Dividing these 2 quantities gives us the above Novocure EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.8x - 15.8x | 12.7x |
| Forward P/E multiples | 13.4x - 18.3x | 15.6x |
| Fair Price | (16.64) - (19.46) | (17.44) |
| Upside | -211.4% - -230.2% | -216.8% |
| Date | EV/EBITDA |
| 2026-10-02 | -13.49 |
| 2026-10-01 | -14.32 |
| 2026-09-30 | -14.35 |
| 2026-09-29 | -14.38 |
| 2026-09-28 | -14.24 |
| 2026-09-25 | -14.25 |
| 2026-09-24 | -14.56 |
| 2026-09-23 | -14.60 |
| 2026-09-22 | -14.96 |
| 2026-09-21 | -14.84 |
| 2026-09-18 | -14.98 |
| 2026-09-17 | -15.00 |
| 2026-09-16 | -14.58 |
| 2026-09-15 | -14.52 |
| 2026-09-14 | -14.58 |
| 2026-09-11 | -13.97 |
| 2026-09-10 | -13.84 |
| 2026-09-09 | -14.07 |
| 2026-09-08 | -15.11 |
| 2026-09-04 | -16.04 |
| 2026-09-03 | -15.79 |
| 2026-09-02 | -15.95 |
| 2026-09-01 | -15.57 |
| 2026-08-31 | -15.80 |
| 2026-08-28 | -15.94 |
| 2026-08-27 | -16.09 |
| 2026-08-26 | -16.00 |
| 2026-08-25 | -15.77 |
| 2026-08-24 | -15.04 |
| 2026-08-21 | -15.33 |
| 2026-08-20 | -15.90 |
| 2026-08-19 | -16.27 |
| 2026-08-18 | -15.45 |
| 2026-08-17 | -15.69 |
| 2026-08-14 | -15.20 |
| 2026-08-13 | -15.57 |
| 2026-08-12 | -15.75 |
| 2026-08-11 | -15.80 |
| 2026-08-10 | -15.51 |
| 2026-08-07 | -14.72 |
| 2026-08-06 | -14.13 |
| 2026-08-05 | -14.43 |
| 2026-08-04 | -14.62 |
| 2026-08-03 | -13.81 |
| 2026-07-31 | -13.40 |
| 2026-07-30 | -13.73 |
| 2026-07-29 | -13.71 |
| 2026-07-28 | -14.65 |
| 2026-07-27 | -15.27 |
| 2026-07-24 | -15.80 |